Clinical Trial Update: Research Into Antipsychotic Discontinuation and Reduction Trial [Phase 4]

View source ↗

Summary

Phase 4 trial updating research on discontinuation and reduction strategies for antipsychotics in schizophrenia-spectrum disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delusional Disorder
• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorders

Snippet

Sponsor: University College, London | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED